February 23, 2023 03:06 PM ESTUpdated February 24, 08:39 AM
Pharma
Law

Ex-Phlow ex­ec, cousin ar­rest­ed in Ko­dak in­sid­er trad­ing scheme

Paul Schloesser

Associate Editor

A for­mer phar­ma­ceu­ti­cal com­pa­ny ex­ec­u­tive and his cousin were ar­rest­ed Thurs­day morn­ing for an in­sid­er trad­ing scheme based on a Covid-re­lat­ed con­tract.

A DOJ an­nounce­ment …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Take­da to pay $200M for rights to ane­mia drug from Keros

Janux soars on ear­ly prostate can­cer da­ta that could chal­lenge No­var­tis' Plu­vic­to

Rev­o­lu­tion sells $600M in shares on back of RAS in­hibitor port­fo­lio up­dates

Roche teams up with Chica­go au­toim­mune biotech COUR Phar­ma­ceu­ti­cals

Ipsen se­cures rights to pre­clin­i­cal T cell en­gager in $610M pact with French biotech

Gilead makes an­oth­er ADC move, ink­ing up to $415M pact with Tubu­lis

A service from the Financial Times